Mike M. Bierle, M.D.

Closed for Enrollment

• Predictive Pharmacogenomics in Fibromyalgia Rochester, Minn.

  The purpose of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients with fibromyalgia in order to improve patient clinical care at Mayo Clinic with more effective and efficient prescribing of medications.